Henry E. Pertinez
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Tuberculosis Research and Epidemiology 14
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 detection and testing 5
- HIV/AIDS drug development and treatment 4
-
- Mycobacterium research and diagnosis 4
- Respiratory viral infections research 2
- Co-authors
- Geraint Davies (11 shared papers)Leon J Aarons (2 shared papers)Charles A. Peloquin (3 shared papers)Jan‐Willem C. Alffenaar (2 shared papers)Yingjun Liu (4 shared papers)Saye Khoo (5 shared papers)Kayode Ogungbenro (1 shared paper)Anthony R. M. Coates (4 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (7 papers)Antimicrobial Agents and Chemotherapy (5 papers)British Journal of Clinical Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Henry E. Pertinez
39 papers receiving 1.1k citations
Henry E. Pertinez's Hit Papers
Peers
Comparison fields: 5 of 110
- Infectious Diseases 548
- Pharmacology 112
- Pharmaceutical Science 53
- Epidemiology 205
- Pharmacology 93
Countries citing papers authored by Henry E. Pertinez
This map shows the geographic impact of Henry E. Pertinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry E. Pertinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry E. Pertinez more than expected).
Fields of papers citing papers by Henry E. Pertinez
This network shows the impact of papers produced by Henry E. Pertinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry E. Pertinez. The network helps show where Henry E. Pertinez may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry E. Pertinez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 Hit paper breakdown → | 2022 | 229 |
| 2 | 2020 | 110 | |
| 3 | 2021 | 92 | |
| 4 | 2011 | 91 | |
| 5 | 2018 | 90 | |
| 6 | 2018 | 89 | |
| 7 | 2020 | 45 | |
| 8 | 2018 | 35 | |
| 9 | 2014 | 28 | |
| 10 | 2015 | 24 | |
| 11 | 2020 | 24 | |
| 12 | 2017 | 23 | |
| 13 | 2021 | 21 | |
| 14 | 2021 | 21 | |
| 15 | 2019 | 21 | |
| 16 | 2016 | 19 | |
| 17 | 2012 | 18 | |
| 18 | 2017 | 17 | |
| 19 | 2020 | 16 | |
| 20 | 2021 | 15 |
About Henry E. Pertinez
Henry E. Pertinez is a scholar working on Infectious Diseases, Epidemiology, Virology, Rheumatology and Hepatology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (14 papers), SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 detection and testing (5 papers), Mycobacterium research and diagnosis (4 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Infectious Diseases (548 citations), Pharmacology (112 citations), Pharmaceutical Science (53 citations), Epidemiology (205 citations) and Pharmacology (93 citations). Henry E. Pertinez has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Geraint Davies, Leon J Aarons, Charles A. Peloquin, Jan‐Willem C. Alffenaar, Yingjun Liu, Saye Khoo, Kayode Ogungbenro, Anthony R. M. Coates, Yanmin Hu and Andrew Owen. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.